Skip to main content

Table 1 Patient profile

From: Impact of serum potassium on therapeutic prognosis of maintenance hemodialysis patients on angiotensin receptor antagonists

    ARB  
   Total (+) (–) p value
Age (Years old) 68.8 ± 6.33 68.1 ± 6.10 70.1 ± 6.71 0.234
Gender (M to F ratio)   149:111 95:72 54:39 0.855
Vintage of dialysis (Years) 5.61 ± 3.25 5.63 ± 3.30 5.56 ± 3.18 0.939
Diabetes   89 63 26 0.112
CAD   50 37 13 0.109
CHF   30 18 12 0.609
Stroke   21 13 8 0.817
SBP at the beginning of session (mmHg) 148.5 ± 9.40 153.2 ± 7.99 140.1 ± 10.3 <0.001
DBP at the beginning of session (mmHg) 74.5 ± 5.44 75.6 ± 5.16 72.4 ± 5.81 0.024
BUN (mg/dL) 63.0 ± 5.25 63.4 ± 5.16 62.5 ± 5.42 0.503
Kt/V   0.96 ± 0.12 0.96 ± 0.11 0.96 ± 0.11 0.997
Alb (g/dL) 3.63 ± 0.19 3.65 ± 0.17 3.60 ± 0.21 0.354
Hb (g/dL) 10.0 ± 0.33 10.0 ± 0.32 10.1 ± 0.35 0.570
CRP (mg/dL) 1.00 ± 0.99 0.97 ± 1.10 1.07 ± 0.77 0.701
K (mEq/L) 5.0 ± 0.3 5.0 ± 0.3 4.9 ± 0.3 0.053
Ca (mg/dL) 8.6 ± 0.3 8.6 ± 0.3 8.5 ± 0.3 0.096
P (mg/dL) 5.3 ± 0.4 5.3 ± 0.4 5.3 ± 0.5 0.928
TC (mg/dL) 155.4 ± 18.4 154.8 ± 18.0 156.3 ± 19.1 0.769
Blood glucose (mg/dL) 123.4 ± 19.9 122.4 ± 19.5 125.3 ± 20.9 0.576
AF   21 10 11 0.098
Changes of ST–T segment in ECG   101 71 30 0.105
HCV infection   18 10 8 0.428
ACEI   20 12 8 0.683
ARB   167 167 0
CCB   186 139 47 <0.001
beta-B   88 66 22 0.009
VD   157 111 46 0.007
Weekly dose of Erythropoietin/DW (U/w/kg) 119.7 ± 44.4 121.5 ± 44.5 116.6 ± 44.6 0.354
  1. CAD coronary artery disease, CHF congestive heart failure, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen, Alb albumin, Hb hemoglobin, CRP C-reactive protein, K serum potassium, Ca calcium, P phosphorus, TC total cholesterol, AF atrial fibrillation, HCV hepatitis C virus, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, beta-B beta receptor blocker, VD vitamin D3, DW dry weight